Delivering commercialization strategies for rare orphan & specialty drugs, cell and gene therapies, and other novel emerging medical innovations.

Diligentia is a biopharma and life sciences consultancy with expertise designing commercialization strategies and tactical plans that enable pre-clinical and clinical stage companies to begin with the end in mind. With an exclusive focus on rare orphan and specialty biopharmaceuticals, we understand and navigate the complexities of the changing commercial landscape, serving as partners to our industry clients. Our comprehensive approach is grounded in real world experience and anticipates future trends while mitigating risk.


Experience Includes:

  • Anti-Infective

  • CNS

  • Endocrinology

  • Hepatology

  • Inherited Metabolic Disorders

  • Nephrology

  • Neurology

  • Oncology

  • Opthalmology

  • Pain Medicine


In an environment where public debate over drug prices and access to medicines has taken center-stage, we help our clients to anticipate and manage commercial risks early and throughout drug development.


  • LinkedIn Social Icon

© 2019 Diligentia LLC

(202) 744-0755